Meeting
2012 Gastrointestinal Cancers Symposium
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial.
Authors
Prajnan Das
University of Texas M. D. Anderson Cancer Center, Houston, TX
Prajnan Das , Cathy Eng , Miguel A. Rodriguez-Bigas , George J. Chang , John Michael Skibber , Dipen Maru , Mark F. Munsell , Marilyn V. Clemons , Scott Kopetz , Chris R. Garrett , Imad Shureiqi , Sunil Krishnan , Marc E. Delclos , Christopher H. Crane
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT00543842
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 544)
DOI
10.1200/jco.2012.30.4_suppl.544
Abstract #
544
Poster Bd #
D19
Abstract Disclosures
Similar Posters
Poster
2012 Gastrointestinal Cancers Symposium
Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer (LAPC).
First Author: Heath Devin Skinner
Poster
2020 Gastrointestinal Cancers Symposium
Phase I study of preoperative capecitabine and lenvatinib with external radiation therapy in locally advanced rectal adenocarcinoma.
First Author: Ankita Tandon
Poster
2014 ASCO Annual Meeting
Phase I study of preoperative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma.
First Author: Gopi Kesaria Prithviraj
Poster
2021 ASCO Annual Meeting
A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study first-stage.
First Author: Stefano Tamberi